Toward a Biological Therapy to Improve Stroke Outcomes After Thrombolytic Therapy.
From University of Massachusetts Medical School, Worcester, MA. Louis.Messina@umassmemorial.org.
Louis M
LM
Messina
D000818:Animals; D004195:Disease Models, Animal; D005260:Female; D005353:Fibronectins / Q000235:genetics*; D017353:Gene Deletion; D006937:Hypercholesterolemia / Q000235:genetics*; D008297:Male; D020521:Stroke / Q000235:genetics*
D005353:Fibronectins
Editorials; acute stroke; cerebral ischemia-reperfusion injury; stroke management; thrombolytic therapy